Literature DB >> 33531383

Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling.

André L Samson1,2, Sarah E Garnish3,2, Joanne M Hildebrand3,2, James M Murphy1,2.   

Abstract

Necroptosis is a lytic, proinflammatory cell death pathway, which has been implicated in host defense and, when dysregulated, the pathology of many human diseases. The central mediators of this pathway are the receptor-interacting serine/threonine protein kinases RIPK1 and RIPK3 and the terminal executioner, the pseudokinase mixed lineage kinase domain-like (MLKL). Here, we review the chronology of signaling along the RIPK1-RIPK3-MLKL axis and highlight how the subcellular compartmentalization of signaling events controls the initiation and execution of necroptosis. We propose that a network of modulators surrounds the necroptotic signaling core and that this network, rather than acting universally, tunes necroptosis in a context-, cell type-, and species-dependent manner. Such a high degree of mechanistic flexibility is likely an important property that helps necroptosis operate as a robust, emergency form of cell death.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2021        PMID: 33531383     DOI: 10.1126/scisignal.abc6178

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  17 in total

1.  Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria.

Authors:  Stefanie M Bader; Simon P Preston; Katie Saliba; Adam Lipszyc; Zoe L Grant; Liana Mackiewicz; Andrew Baldi; Anne Hempel; Michelle P Clark; Thanushi Peiris; William Clow; Jan Bjelic; Michael D Stutz; Philip Arandjelovic; Jack Teale; Fashuo Du; Leigh Coultas; James M Murphy; Cody C Allison; Marc Pellegrini; Andre L Samson
Journal:  Cell Death Differ       Date:  2022-07-23       Impact factor: 12.067

Review 2.  The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Authors:  Leonid N Maslov; Sergey V Popov; Natalia V Naryzhnaya; Alexandr V Mukhomedzyanov; Boris K Kurbatov; Ivan A Derkachev; Alla A Boshchenko; Igor Khaliulin; N Rajendra Prasad; Nirmal Singh; Alexei Degterev; Evgenia A Tomilova; Ekaterina V Sapozhenkova
Journal:  Apoptosis       Date:  2022-08-20       Impact factor: 5.561

3.  Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Authors:  Ashish Sethi; Christopher R Horne; Cheree Fitzgibbon; Karyn Wilde; Katherine A Davies; Sarah E Garnish; Annette V Jacobsen; André L Samson; Joanne M Hildebrand; Ahmad Wardak; Peter E Czabotar; Emma J Petrie; Paul R Gooley; James M Murphy
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

4.  Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis.

Authors:  Taide Wang; Doris Tomas; Nirma D Perera; Brittany Cuic; Sophia Luikinga; Aida Viden; Samantha K Barton; Catriona A McLean; André L Samson; Adam Southon; Ashley I Bush; James M Murphy; Bradley J Turner
Journal:  Cell Death Differ       Date:  2021-12-02       Impact factor: 12.067

Review 5.  Recent advances in Extracellular Vesicles and their involvements in vasculitis.

Authors:  Nan Yang; Yin Zhao; Xiuhua Wu; Na Zhang; Haoming Song; Wei Wei; Ming-Lin Liu
Journal:  Free Radic Biol Med       Date:  2021-05-02       Impact factor: 8.101

6.  A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells.

Authors:  André L Samson; Cheree Fitzgibbon; Komal M Patel; Joanne M Hildebrand; Lachlan W Whitehead; Joel S Rimes; Annette V Jacobsen; Christopher R Horne; Xavier J Gavin; Samuel N Young; Kelly L Rogers; Edwin D Hawkins; James M Murphy
Journal:  Cell Death Differ       Date:  2021-02-15       Impact factor: 12.067

7.  Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.

Authors:  Sarah E Garnish; Yanxiang Meng; Akiko Koide; Jarrod J Sandow; Eric Denbaum; Annette V Jacobsen; Wayland Yeung; Andre L Samson; Christopher R Horne; Cheree Fitzgibbon; Samuel N Young; Phoebe P C Smith; Andrew I Webb; Emma J Petrie; Joanne M Hildebrand; Natarajan Kannan; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Nat Commun       Date:  2021-04-13       Impact factor: 14.919

8.  A family harboring an MLKL loss of function variant implicates impaired necroptosis in diabetes.

Authors:  Joanne M Hildebrand; Bernice Lo; Sara Tomei; Valentina Mattei; Samuel N Young; Cheree Fitzgibbon; James M Murphy; Abeer Fadda
Journal:  Cell Death Dis       Date:  2021-04-01       Impact factor: 8.469

9.  Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.

Authors:  Yanxiang Meng; Katherine A Davies; Cheree Fitzgibbon; Samuel N Young; Sarah E Garnish; Christopher R Horne; Cindy Luo; Jean-Marc Garnier; Lung-Yu Liang; Angus D Cowan; Andre L Samson; Guillaume Lessene; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Nat Commun       Date:  2021-11-22       Impact factor: 14.919

Review 10.  The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease.

Authors:  Emma C Tovey Crutchfield; Sarah E Garnish; Joanne M Hildebrand
Journal:  Biomolecules       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.